$7M Series B Puts Investor Skin in Game for Brickell
By Catherine Shaffer
Wednesday, February 27, 2013
Brickell Biotech Inc., of Miami, landed a $7 million Series B financing with a new partner, Amorepacific Ventures, which is affiliated with Amorepacific Group, a large Korean aesthetics company.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.